Genomics of Peripheral T-Cell Lymphoma
Peripheral T-cell lymphoma (PTCL) is a group of rare diseases that collectively comprise 15 percent of lymphomas. The diseases are poorly understood and often have poor prognosis. Memorial Sloan-Kettering Cancer Center has one of the highest volumes of PTCL patients the country. This provides opportunity to study the disease by analyzing patient samples. Initially, we will perform sequencing of tumor DNA to identify genes involved in PTCL development. These results will shed new light on these diseases and inspire further studies. The generous award from the Gabrielle’s Angel Foundation will fully fund our initial set of analyses.